Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Risk & Compliance
Is Your Internal Control Environment Up to Date?
Assessing the state of your current framework is crucial to ensure its effectiveness.
By
Mary Wisenski
| June 28, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Merck
People
CFOs On the Move: Week Ending March 26
Condé Nast, Foot Locker, Velocity, Merck, DNA Script, Ibotta, Cano Health, Ring Energy, PG&E, Adobe
By
Lauren Muskett
| March 26, 2021
Read More
People
CFOs On the Move: Week Ending February 5
Merck, Fetch Rewards, L Brands, Royal Cup Coffee & Tea, The Children’s Place, SMART Global Holdings, RealNetworks, Idea Financial, Virta Health
By
Lauren Muskett
| February 5, 2021
Read More
Risk & Compliance
Merck Drops Out of COVID-19 Vaccine Race
Merck's announcement that it is shelving its two vaccine candidates "marks a shocking setback for one of the most storied vaccine makers."
By
Matthew Heller
| January 25, 2021
Read More
M&A
Merck Buys OncoImmune in COVID Treatment Move
The $425 million deal gives Merck access to a promising therapy for treating seriously ill COVID-19 patients.
By
Matthew Heller
| November 23, 2020
Read More
M&A
Merck Enters Race to Develop COVID Vaccine
The world's largest vaccine maker is no longer on the COVID sidelines after acquiring an Austrian biotech and teaming up with a nonprofit.
By
Matthew Heller
| May 26, 2020
Read More
M&A
Merck, Sanofi in Deals for Cancer Drug Firms
The pharma giants each announced they would buy smaller drugmakers to expand cancer-treatment franchises.
By
Lauren Muskett
| December 9, 2019
Read More
M&A
Merck Goes Hostile in Versum Takeover Battle
Versum shareholders are scheduled to vote next month on a merger with Entegris that is valued at less than Merck's $5.9 billion proposal.
By
Matthew Heller
| March 27, 2019
Read More
M&A
Bayer to Shed Assets, Cut Jobs Amid Share Pressure
It's a broad restructuring of the German conglomerate, which plans to sell its sun-care and foot care businesses and exit its animal health division.
By
William Sprouse
| November 29, 2018
Read More
M&A
P&G Buys Merck Unit to Boost OTC Business
The $4 billion acquisition of Merck's consumer healthcare unit comes amid investor pressure on P&G to increase sales.
By
Matthew Heller
| April 19, 2018
Read More
Risk Management
Data Held Hostage
The damage inflicted in this year’s ransomware attacks will force corporations to review their IT resilience.
By
Vincent Ryan
| September 28, 2017
Read More
Technology
Quantifying Cyber Risks
Companies are clamoring for the data and information they need to manage their exposures.
By
David Katz
| December 15, 2016
Read More
Strategy
Merck Buys Cough Drug Developer for $1.25B
The acquisition of Afferent Pharmaceuticals gives Merck access to a drug candidate for treating neurogenic conditions including chronic cough.
By
Katie Kuehner-Hebert
| June 10, 2016
Read More
Risk & Compliance
Ex-Merck Analyst Hit with Insider Trading Rap
He allegedly helped a friend make more than $700,000 on insider M&A info.
By
Matthew Heller
| October 15, 2014
Read More
Staffing
CFOs on the Move: Week Ended March 28
Merck, AlixPartners, Laboratory Corp. of America, Catamaran, Bell and Howell, Cyan, RealPage, WPX Energy
By
Joan Urdang
| March 28, 2014
Read More
Technology
Transforming Cisco: One Finance Function At a Time
Cisco's shares have made a comeback, and CFO Frank Calderoni says a finance unit revamp was one of the key pieces of the company's turnaround.
By
Kathy Hoffelder
| October 10, 2013
Read More
Next